Roubille, C., Pelletier, J.P., Martel-Pelletier, J.: Drug/Agent Treatments for Osteoarthritis   Present and Future. In: Osteoarthritis: Pathogenesis, diagnosis, available treatments, drug safety, regenerative and personalized medicine. Kapoor, M. and Mahomed, N.N., eds. Springer, New York, NY, U.S.A.  Chapter 10, pp 191-210, 2015.

Pelletier, J.P., Martel-Pelletier, J.: La glucosamine peut soigner l'arthrose. Le Bulletin des Diplômés de l'Université de Montréal. No. 429:24, 2015. 

Otis, C., Guillot, M., Moreau, M., Martel-Pelletier, J., Pelletier, J.P., Beaudry, F., Troncy, E.: Spinal neuropeptide modulation, functional assessment and cartilage lesions in a monosodium iodoacetate rat model of osteoarthritis. Neuropeptides 65:56-62, 2017.

Martel-Pelletier, J., Raynauld, J.P., Mineau, F., Abram, F., Paiement, P., Delorme, P., Pelletier, J.P.: Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study. Arthritis Res. Ther. 19(1):169, 2017.

Monteiro, B.P., Klinck, M.P., Moreau, M., Guillot, M., Steagall, P.V.M., Pelletier, J.P., Martel-Pelletier, J., Gauvin, D., del Castillo, JRE., Troncy, E.: Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis. PLOS ONE 12(4):e0175565, 2017.

Pelletier, J.P., Raynauld, J.P., Beaulieu, A., Bessette, L., Morin, F., de Brum-Fernandes, A.J., Delorme, P., Dorais, M., Paiement, P., Abram, F., Martel-Pelletier, J.: Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study. Arthritis Res. Ther. 18(1):256, 2016.

Monteiro, B.P., Pelletier, J.P., Martel-Pelletier, J., Gauvin, D., Del Castillo, J.R., Troncy, E.: Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis. Vet. Anaesth. Analg. 43(6):643-651, 2016.

Otis, C., Gervais, J., Guillot, M., Gervais, J.A., Gauvin, D., Pethel, C., Authier, S., Dansereau, M.A., Sarret, P., Martel-Pelletier, J., Pelletier, J.P., Beaudry, F., Troncy, E.: Concurrent validity of different functional and neuroproteomic pain assessment methods in the rat osteoarthritis MIA model. Arthritis Res. Ther. 18:150, 2016.

Raynauld, J.P., Pelletier, J.P., Abram, F., Delorme, P., Martel-Pelletier, J.: Long-term effects of glucosamine and chondroitin sulfate on the progression of structural changes in knee osteoarthritis: Six-year followup data from the Osteoarthritis Initiative. Arthritis Care Res. 68(10):1560-1566, 2016.

Martel-Pelletier, J., Valverde Franco, G., Pelletier, J.P.: The ephrin-B2/EphB4 system is required in musculoskeletal development and protects the articulation during osteoarthritis: a research highlight. Receptors Clin. Investig. 2016;3:e1426.

Li, Y-H., Tardif, G., Hum, D., Kapoor, M., Fahmi, H., Pelletier, J.P., Martel-Pelletier, J.: The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target. Arthritis Res. Ther. 18:172, 2016.

Valverde-Franco, G., Lussier, B., Hum, D., Wu, J., Hamadjida, A., Dancause, N., Fahmi, H., Kapoor, M., Pelletier, J.P., Martel-Pelletier, J.: Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo. Arthritis Care Res.18(1):65, 2016.

Martel-Pelletier, J., Raynauld, J.P., Dorais, M., Abram, F., Pelletier, J.P.: The levels of the adipokines adipsin and leptin are associated with knee OA progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis. Rheumatology. 55(4):680-8, 2016.

Martel-Pelletier, J., Roubille, C., Abram, F., Hochberg, M.C., Dorais, M., Delorme, P., Raynauld, J.P., Pelletier, J.P.: First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteorathritis initiative progression cohort. Ann. Rheum. Dis. 74(3):547-556, 2015.

Pelletier, J.P., Roubille, C., Raynauld, J.P., Abram, F., Dorais, M., Delorme, P., Martel-Pelletier, J.: Disease modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss. Ann. Rheum. Dis. 74(2):422-429, 2015.

Roubille, C., Martel-Pelletier, J., Abram, F., Dorais, M., Delorme, P., Raynauld, J-P., Pelletier, J.P.: Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: Data from the OAI progression cohort. Semin. Arthritis Rheum. 45(3):257-267, 2015.

Farran, A., Valverde-Franco, G., Tio, L., Lussier, B., Fahmi, H., Pelletier, J.P., Bishop, P., Monfort, J., Martel-Pelletier, J.: In vivo effect of opticin deficiency in a surgically induced mouse model of osteoarthritis. Arthritis Rheumatol. 69 (S10):52, 2017; Osteoarthritis Cartilage 25(Suppl 1):S61, 2017; 5th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P25, pp 49. Gold Coast, Australia (August 2017).

Pelletier, J.P., Raynauld, J.P., Abram, F., Dorais, M., Delorme, P., Martel-Pelletier, J.: Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: data from the OAI. Arthritis Rheumatol. 69 (S10):1197, 2017; 5th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P30, pp 50-51. Gold Coast, Australia (August 2017).

Martel-Pelletier, J., Raynauld, J.P., Mineau, F., Abram, F., Paiement, P., Delorme, P., Pelletier, J.P.: Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed buy MRI: An exploratory study. Arthritis Rheumatol. 69 (S10):1208, 2017; 5th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P24, pp 48-49. Gold Coast, Australia (August 2017).

Pelletier, J.P., Raynauld, J.P., Beaulieu, A., Bessette, L., Morin, F., de Brum-Fernandes, A.J., Abram, F., Dorais, M., Martel-Pelletier, J.: In a two-year double-blind randomized controlled multicenter study, chondroitin sulfate was significantly superior to celecoxib at reducing cartilage loss with similar efficacy at reducing disease symptoms in knee osteoarthritis patients. Arthritis Rheumatol. 67 (Suppl 10):1243, 2015;  Ann. Rheum. Dis. 75(Suppl 2):836, 2016; Osteoarthritis Cartilage 24(Suppl 1):S189-90, 2016.

Pelletier, J.P.: Structure modifying treatments of OA: DMOADs are tomorrow’s treatment. Osteoporos Int. 27(Suppl 1):S77, 2016.

Pelletier, J.P.: Safety and risk/benefit ratio of diacerein in the management of osteoarthritis. Osteoporos Int. 27(Suppl 1):S68, 2016.

Pelletier, J.P.: Efficacy and safety of oral and topical NSAIDs plus analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys. Osteoporos Int. 27(Suppl 1):S65-6, 2016

Otis, C., Guillot, M., Moreau, M., Bedard, A., Gaumond, I., Pelletier, J.P., Martel-Pelletier, J., Beaudry, F., Lussier, B., Lecompte, R., Marchand, S., Troncy, E.: Oestradiol supplementation in a surgical rodent model of osteoarthritis pain. 4th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). OR03, pp 54. Barcelona, Spain (October 2016).

Otis, C., Gervais, J., Guillot, M., Gervais, J.-A., Gauvin, D., Péthel, C., Authier, S., Dansereau, M.-A., Sarret, P., Martel-Pelletier, J., Pelletier, J.P., Beaudry, F., Troncy, E.: Concurrent validity of different functional and neuroproteomic pain assessment methods in the rat osteoarthritis monosodium iodoacetate (MIA) model. 4th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P04, pp 60-61. Barcelona, Spain (October 2016).

Otis, C., Guillot, M., Moreau, M., Pelletier, J.P., Martel-Pelletier, J., Beaudry, F., Troncy, E.: Spinal neuropeptides modulation and macroscopic cartilaginous lesions in a chemical rodent model of osteoarthritis. 4th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P05, pp 61. Barcelona, Spain (October 2016).

Otis, C., Moreau, M., Guillot, M., Burney, E., Hiu Tung, V.C., Laroche, J., Gagnon, A., Bedard, A., Pelletier, J.P., Martel-Pelletier, J., Beaudry, F., Lussier, B., Chemtob, S., Troncy, E.: Analgesic efficacy of rytvela in a surgical rodent model of osteoarthritis pain. 4th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P06, pp 61-62. Barcelona, Spain (October 2016).

Monteiro, B.P., Klinck, M., Moreau, M., Guillot, M., Steagall, P., Pelletier, J.P., Martel-Pelletier, J., Gauvin, D., del Castillo, J., Troncy, E.: Analgesic efficacy of tramadol administered orally for two weeks in cats with naturally occurring osteoarthritis. 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P17, pp 64. Montréal, Canada (April 2015).

Valverde-Franco, G., Lussier, B., Fahmi, H., Hum, D., Wu, J., Dancause, N., Hamadjida, A., Pelletier, J.P., Kapoor, M., Martel-Pelletier, J.: In vivo cartilage-specific deletion of ephrin-B2 in mice results in bone development leading to osteoarthritis features. 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P29, pp 69. Montréal, Canada (April 2015).

Guillot, M., Rialland, P., Taylor, Polly, M., Rousseau, J.A., Beaudoin, J.F., Chartrand, G., Pelletier, J.P., Martel-Pelletier, J., de Guise, J.A., Lecomte, R., Troncy, E.: Osteoarthritis-associated pain in cats: proofs of central sensitization development. 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). P09, pp 60. Montréal, Canada (April 2015).

Martel-Pelletier, J., Raynauld, J.P., Roubille, C., Pelletier, J.P.: Are muscle area, muscle fat and adipokines risk factors for osteoarthritis? 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). S14, pp 33. Montréal, Canada (April 2015).